Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for emergence agitation after general anesthesia
ChiCTR2100048629Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Emergence agitation (EA) comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Restlessness and sedation score. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2100048629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048629.